Australia markets closed

CASI Pharmaceuticals Inc (ENM.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.52000.0000 (0.00%)
At close: 10:38AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
33,879
33,879
43,107
30,168
15,141
Cost of revenue
13,827
13,827
15,827
12,557
9,508
Gross profit
20,052
20,052
27,280
17,611
5,633
Operating expenses
Research development
9,861
9,861
15,996
14,422
11,470
Selling general and administrative
41,837
41,837
37,775
38,406
27,476
Total operating expenses
45,332
45,332
53,771
52,828
38,946
Operating income or loss
-25,280
-25,280
-26,491
-35,217
-33,313
Total other income/expenses net
-1,626
-1,626
-11,067
-946
-15,064
Income before tax
-26,292
-26,292
-37,431
-35,842
-47,511
Income tax expense
-81
-81
1,980
0
0
Income from continuing operations
-26,259
-26,259
-40,257
-35,842
-47,511
Net income
-26,938
-26,938
-41,014
-36,654
-48,287
Net income available to common shareholders
-26,960
-26,960
-41,014
-36,654
-48,287
Basic EPS
-3.01
-
-3.01
-2.69
-4.37
Diluted EPS
-3.01
-
-3.01
-2.69
-4.37
Basic average shares
13,647
-
13,647
13,610
11,045
Diluted average shares
13,647
-
13,647
13,610
11,045